@Chuxa (can't reply to your actual message for some reason)
Good objective response. While we may have different opinions, you've been able to clearly articulate your issues which is what the forum is all about.
As an aside on the JV, one of the key reasons why the terms were what they were is that Roadpost had an established distribution network in the largest market. That's what they brought to the JV. It's difficult, long and expensive to set one up by yourself and we didn't have the financial capacity to do so.
If you will recall, Roadpost even funded a loan to us for some of the Zoleo start up capital. I guess the thinking was that having 50% of a bigger business is better than having 100% of an underfunded smaller business. Obviously as Zoleo scaled, it didn't age well and the majority of the profits went to RP, which was unfortunate but just sharing the state of play at the time.
- Forums
- ASX - By Stock
- BCC
- Ann: Dates for First Half FY24 Results & Investor Webinar
Ann: Dates for First Half FY24 Results & Investor Webinar, page-16
-
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCC (ASX) to my watchlist
|
|||||
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $13.82M |
Open | High | Low | Value | Volume |
15.5¢ | 16.0¢ | 15.5¢ | $11.19K | 70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 34766 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22499 | 0.135 |
2 | 59099 | 0.110 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 34766 | 1 |
0.185 | 7500 | 1 |
0.200 | 25000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 10.01am 11/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
BCC (ASX) Chart |